Protein Binder for Affinity Purification of Human Immunoglobulin Antibodies

被引:25
作者
Heu, Woosung [1 ]
Choi, Jung-Min [1 ]
Lee, Joong-Jae [1 ]
Jeong, Sukyo [1 ]
Kim, Hak-Sung [1 ]
机构
[1] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea
关键词
ALKALINE STABILITY; PEPTIDE LIGAND; CHROMATOGRAPHY; FC; IGG; PH; CONFORMATION; AGGREGATION; CULTURE; SYSTEMS;
D O I
10.1021/ac501158t
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The importance of a downstream process for the purification of immunoglobulin antibodies is increasing with the growing application of monoclonal antibodies in many different areas. Although protein A is most commonly used for the affinity purification of antibodies, certain properties could be further improved: higher stability in alkaline solution and milder elution condition. Herein, we present the development of Fc-specific repebody by modular engineering approach and its potential as an affinity ligand for purification of human immunoglobulin antibodies. We previously developed the repebody scaffold composed of Leucine-rich repeat (LRR) modules. The scaffold was shown to be highly stable over a wide range of pH and temperature, exhibiting a modular architecture. We first selected a repebody that binds the Fc fragment of human immunoglobulin G (IgG) through a phage display and increased its binding affinity up to 1.9 x 10(-7) M in a module-by-module approach. The utility of the Fc-specific repebody was demonstrated by the performance of an immobilized repebody in affinity purification of antibodies from a mammalian cell-cultured medium. Bound-antibodies on an immobilized repebody were shown to be eluted at pH 4.0 with high purity (>94.6%) and recovery yield (>95.7%). The immobilized repebody allowed a repetitive purification process more than ten times without any loss of binding capability. The repebody remained almost intact even after incubation with 0.5 M NaOH for 15 days. The present approach could be effectively used for developing a repeat module-based binder for other target molecules for affinity purification.
引用
收藏
页码:6019 / 6025
页数:7
相关论文
共 40 条
  • [1] Small-Molecule-Based Affinity Chromatography Method for Antibody Purification via Nucleotide Binding Site Targeting
    Alves, Nathan J.
    Stimple, Samuel D.
    Handlogten, Michael W.
    Ashley, Jonathan D.
    Kiziltepe, Tanyel
    Bilgicer, Basar
    [J]. ANALYTICAL CHEMISTRY, 2012, 84 (18) : 7721 - 7728
  • [2] Antibody purification by affinity chromatography based on small molecule affinity ligands identified by SPR-based screening of chemical microarrays
    Arnold, Marc
    Bittermann, Holger
    Kalbfuss-Zimmermann, Bernd
    Neumann, Thomas
    Schmidt, Kristina
    Sekul, Renate
    Hilbrig, Frank
    Ludolph, Heiko
    Freitag, Ruth
    [J]. JOURNAL OF CHROMATOGRAPHY A, 2011, 1218 (29) : 4649 - 4659
  • [3] Aspiund M., 2000, PROCESS BIOCHEM, V35, P1111
  • [4] Affinity chromatography as a tool for antibody purification
    Ayyar, B. Vijayalakshmi
    Arora, Sushrut
    Murphy, Caroline
    O'Kennedy, Richard
    [J]. METHODS, 2012, 56 (02) : 116 - 129
  • [5] Laboratory scale Clean-In-Place (CIP) studies on the effectiveness of different caustic and acid wash steps on the removal of dairy biofilms
    Bremer, PJ
    Fillery, S
    McQuillan, AJ
    [J]. INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 2006, 106 (03) : 254 - 262
  • [6] Affinity chromatography matures as bioinformatic and combinatorial tools develop
    Clonis, YD
    [J]. JOURNAL OF CHROMATOGRAPHY A, 2006, 1101 (1-2) : 1 - 24
  • [7] Dye-ligand affinity systems
    Denizli, A
    Piskin, E
    [J]. JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, 2001, 49 (1-3): : 391 - 416
  • [8] Effects of acid exposure on the conformation, stability, and aggregation of monoclonal antibodies
    Ejima, Daisuke
    Tsumoto, Kouhei
    Fukada, Harumi
    Yumioka, Ryosuke
    Nagase, Kazuo
    Arakawa, Tsutomu
    Philo, John S.
    [J]. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2007, 66 (04) : 954 - 962
  • [9] Therapeutic antibodies: Market considerations, disease targets and bioprocessing
    Elvin, John G.
    Couston, Ruairidh G.
    van der Walle, Christopher F.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 440 (01) : 83 - 98
  • [10] Gottschalk U., 2009, PROCESS SCALE PURIFI